Dr. Daniela Matei, MD
Claim this profileNorthwestern University
Studies Endometrial Adenocarcinoma
Studies Endometrial Cancer
6 reported clinical trials
18 drugs studied
Area of expertise
1Endometrial Adenocarcinoma
Stage III
Stage IV
MMR negative
2Endometrial Cancer
Stage IV
Stage III
ER positive
Affiliated Hospitals
Clinical Trials Daniela Matei, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Iohexol-aided Carboplatin Dosing
for Cancer
This trial studies how well iohexol helps doctors calculate the dose of carboplatin for cancer patients. By measuring kidney function more accurately, doctors can improve the effectiveness and safety of carboplatin treatment. Carboplatin is a platinum-based chemotherapy drug used to treat various cancers, known for its improved toxicity profile compared to cisplatin.
Recruiting1 award Phase 17 criteria
More about Daniela Matei, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniela Matei, MD has experience with
- Carboplatin
- Abemaciclib
- Alpelisib
- Aromatase Inhibitor (AI)
- Everolimus
- LY3484356
Breakdown of trials Daniela Matei, MD has run
Endometrial Adenocarcinoma
Endometrial Cancer
Uterine Cancer
Fallopian Tube Carcinosarcoma
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniela Matei, MD specialize in?
Daniela Matei, MD focuses on Endometrial Adenocarcinoma and Endometrial Cancer. In particular, much of their work with Endometrial Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Daniela Matei, MD currently recruiting for clinical trials?
Yes, Daniela Matei, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Daniela Matei, MD has studied deeply?
Yes, Daniela Matei, MD has studied treatments such as Carboplatin, Abemaciclib, Alpelisib.
What is the best way to schedule an appointment with Daniela Matei, MD?
Apply for one of the trials that Daniela Matei, MD is conducting.
What is the office address of Daniela Matei, MD?
The office of Daniela Matei, MD is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.